http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109481414-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate | 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109481414-B |
| titleOfInvention | A kind of idecalcidol soft capsule |
| abstract | The invention relates to an idecalcidol soft capsule, which belongs to the field of pharmaceutical preparations. The invention provides an idecalcidol soft capsule, which is composed of a capsule shell and contents, wherein the contents include idecalcidol, a solvent, a latent solvent and a stabilizer. In the present invention, the formulation of idecalcidol soft capsules is optimized and screened, and the solvent, co-solvent and stabilizer are mainly screened. It is composed of methanol, and the stabilizer is selected from tert-butyl hydroquinone. After the stability test research, the stability of the idecalcitol soft capsule of the present invention meets the requirements. |
| priorityDate | 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.